| Application no. and date | 12721268.6 (espacenet) (Federated) (European Patent Register), 20120511 | | Patent/reg. no. and date | DK/EP 2707015, 20161109 | | Publication date | 20140319 | | Priority no. and date | EP 11166111, 20110513 | | EP pub. no. and date |
EP 2707015 20140319 | | Effective date | | | Applicant/owner | Sanofi-Aventis Deutschland GmbH, Brüningstraße 50
65929 Frankfurt am Main, DE | | Applicant ref. no. | SAN DE2011-108-EP-EPT | | Inventor | SILVESTRE, Louise, c/o Sanofi
Département Brevets
54 rue La Boétie
F-75008 Paris, FR,
BOKA, Gabor, c/o Sanofi
Département Brevets
54 rue La Boétie
F-75008 Paris, FR,
MIOSSEC, Patrick, c/o Sanofi
Département Brevets
54 rue La Boétie
F-75008 Paris, FR,
NIEMÖLLER, Elisabeth, c/o Sanofi-Aventis Deutschland GmbH
65926 Frankfurt am Main, DE | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | A61K 31/155 (2006.01) , A61K 38/26 (2006.01) , A61K 38/28 (2006.01) , A61P 3/04 (2006.01) , A61P 3/10 (2006.01) | | Title | LIXISENATID SOM TILLÆGSBEHANDLING TIL BASISINSULIN VED TYPE 2-DIABETES | | Int. application no. | EP2012058749 | | Int. publication no. | WO2012156299 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
